CASE REPORT: A 30-YEAR-OLD ORAL CONTRACEPTIVE USER WITH MILD COVID-19

Dr. Tanvir Ahmad, MBBS, MD (Hepatology)*, Dr. Tahmina Begum Tuhin and Dr. Monowara Begum

ABSTRACT

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a prothrombotic state and an increased incidence of thromboembolic disease. Non-hospitalized patients with COVID-19 should not routinely be tested for measures of coagulopathy, such as D-dimer level, prothrombin time, fibrinogen level, and platelet count. Although abnormalities of these markers have been associated with worse outcomes, there is a lack of prospective data demonstrating that they can be used for risk stratification in those who are asymptomatic or those with mild SARS-CoV-2 infection. Here we described a remarkably mild case of COVID-19 in a 30-year-old female who has been taking oral contraceptive pill (OCP) for more than two years and she was found of having very high D-dimer level (2320 μg/L). The case demonstrates that taking OCP for long time can be considered as a comorbid condition and thromboprophylaxis should be given in patients with mild COVID-19 to prevent thromboembolic disease.

Keywords: D-dimer level, prothrombin time, fibrinogen level, and platelet count.